lirafugratinib; RLY-4008

Non Chimik:

N-[4-(4-amino-5-{3-fluoro-4-[(4-methylpyrimidin-2-yl)oxy]phenyl}-7-methyl-7H-pyrrolo[2,3-d]pyrimidin- 6-yl)fenil]-2-methylprop-2-enamid

Kòd SMILES:

C=C(C)C(NC1=CC=C(C2=C(C3=CC=C(OC4=NC=CC(C)=N4)C(F)=C3)C5=C(N)N= CN = C5N2C) C = C1) = O

Kòd InChi:

InChI=1S/C28H24FN7O2/c1-15(2)27(37)35-19-8-5-17(6-9-19)24-22(23-25(30)32-14-33-26( 23)36(24 )4)18-7-10-21(20(29)13-18)38-28-31-12-11-16(3)34-28/h5-14H,1H2,2-4H3,(H, 35,37)(H2,30,32,33)

InChi kle:

XOQVZSSDIQQUGO-UHFFFAOYSA-N

Mot:

2549174-42-5；CAS: 2549174-42-5；CAS:2549174-42-5；Lirafugratinib; RLY-4008; RLY 4008; RLY4008

Solibilite: 

Depo:Sèk, nwa ak nan 0 - 4 C pou kout tèm (jou a semèn) oswa -20 C pou tèm long (mwa a ane).

Deskripsyon:

Lirafugratinib (RLY-4008) se yon inibitè FGFR2 aktif oralman, irevokabl, ak trè selektif.

Sib: FGFR2